NCT06934564 De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
| NCT ID | NCT06934564 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Breast Lumpectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 16 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 16 participants in total. It began in 2025-04-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.
Eligibility Criteria
Site Inclusion Criteria: * Over 30% of testing rates on at least one of the three index procedures (breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair) Exclusion Criteria: * none Surgical participants must be over 18 years old.
Contact & Investigator
Lesly Dossett, MD, MPH
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT06934564 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Lumpectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06934564 currently recruiting?
Yes, NCT06934564 is actively recruiting participants. Contact the research team at greenejr@med.umich.edu for enrollment information.
Where is the NCT06934564 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT06934564 clinical trial?
NCT06934564 is sponsored by University of Michigan. The principal investigator is Lesly Dossett, MD, MPH at University of Michigan. The trial plans to enroll 16 participants.